Excited to announce Aubrey Rankin’s appointment to Nanostics’ Board of Directors! Read more at https://t.co/jHlwqP7nCV or https://t.co/bK1pzFRAFQ
#ProstateCancer#ClarityDXProstate#diagnosis
Excited to announce receiving the CE Mark for its ClarityDX Prostate® test that uses machine-learning plus biological and clinical biomarker data to generate a risk score for clinically significant prostate cancer. https://t.co/ahuEjdnbFo
Entos’ COVID-19 vaccine Phase trial met 1st milestone-thank you Halifax! CCfV is now enrolling Halifax area adults to complete the trial. Interested? Learn more at https://t.co/ZnOgFoatu7 #COVID19Vaccines@Bioalberta@DalhousieU @VACCres @GPAinsights@UofAResearch
Catalina Vasquez and Colin Coros want to thank @jfedeyko Joanne Fedeyko at @connectsv for this excellent opportunity to meet and have discussions with Silicon Valley entrepreneurs, VC, and inspirational coaches.
#CanadianLandingPad#startup#SiliconValley
Nanostics accepts the challenge! Our study Monitor/Data Manager, Aditya Muley, will be at this course too. Meet with Aditya to get your awesome UofA (size med) hoodie!
CSO Desmond Pink @pinknewfie is in Miami, Florida this week to give a talk on Nanostics' liquid biopsy, ClarityDX Prostate at AACR's Advances in Liquid Biopsies. Must See! DM Desmond to chat on #EVs#Extracellularvesicles#flowcytometry#AACRLB20
Add John Lewis' presentation on Nanostics and ClarityDX Prostate-highly accurate aggressive prostate cancer test- to your #JPM20 calendar! #biotechshowcase, Hilton Union Square, Monday, Jan 13, 4:45 pm. DM Catalina @catavasher or Colin @aminostrategies to meet! #diagnostics
We're in San Francisco for #JPM20! Entos develops next-gen nucleic acid-therapies with our proprietary delivery system: Fusogenix. DM CEO John Lewis @APCaRI_CA and CSO Arun Raturi @arunraturi to learn more! https://t.co/Qrxzv5hPne #biopharma#HealthTech#JPM2020
The men of @Nanostics R&D; Mike Wong, @renjithpillai78 and Desmond Pink @pinknewfie say, "Grow a Mo, save a Bro" and that's what they did. Go to https://t.co/BHmyI5S05Z to find out about ClarityDX Prostate. #Movember#ProstateCancer
Going to the BIO Investor Forum company talks? CEO John Lewis is presenting on Oct 22. John and CCO Colin Coros look forward to chatting about our diagnostic platform and lead product ClarityDX Prostate. More at https://t.co/EcyO5md3JI #BIF19#diagnostics#prostatecancer
We're expanding our @Nanostics ClarityDX Prostate clinical validation study into the US with a recruitment site at Century Clinical Research Inc., Daytona Beach, FL. Read more at https://t.co/zW6e5kqFh1 https://t.co/vkzdwOZUjW #clinicaltrials#ProstateCancer
Great @AlbertaImpact “live” episode with our COO Catalina Vasquez @catavasher and CCO Colin Coros @aminostrategies! Watch to learn more about our Prostate Cancer diagnostic test. https://t.co/zHkZcATFhV
We're at ASEMV2019 in Pacific Grove, CA and looking forward to meeting you at our CEO John Lewis' talk and our booth to chat about EVs, uFCM and diagnostics! https://t.co/EcyO5md3JI #extracellularvesicles#ASEMV2019
@entospharma is excited to announce a new partnership with a clinical-stage biopharma company to develop new therapeutics with our Fusogenix tech to target autoimmune and inflammatory diseases. https://t.co/iLCbcuUGNE #pressreleases#immunotherapy#nextgeneration